Sestrins as a Therapeutic Bridge between ROS and Autophagy in Cancer

M Sánchez-Álvarez, R Strippoli, M Donadelli… - Cancers, 2019 - mdpi.com
The regulation of Reactive Oxygen Species (ROS) levels and the contribution therein from
networks regulating cell metabolism, such as autophagy and the mTOR-dependent nutrient …

[HTML][HTML] The function of miR-200 family in oxidative stress response evoked in cancer chemotherapy and radiotherapy

J Kozak, K Jonak, R Maciejewski - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Since the beginning of the discovery of microRNAs (miRs), these molecules have attracted
highly progressive attention due to their powerful regulatory roles in a broad spectrum of …

Targeting prostate tumor low–molecular weight tyrosine phosphatase for oxidation-sensitizing therapy

SM Stanford, TP Nguyen, J Chang, Z Zhao… - Science …, 2024 - science.org
Protein tyrosine phosphatases (PTPs) play major roles in cancer and are emerging as
therapeutic targets. Recent reports suggest low–molecular weight PTP (LMPTP)—encoded …

TUBB3 reverses resistance to docetaxel and cabazitaxel in prostate cancer

Y Sekino, X Han, T Kawaguchi, T Babasaki… - International journal of …, 2019 - mdpi.com
Recent studies have reported that TUBB3 overexpression is involved in docetaxel (DTX)
resistance in prostate cancer (PCa). The aim of this study was to clarify the role of TUBB3 in …

New small-molecule glycoconjugates of docetaxel and GalNAc for targeted delivery to hepatocellular carcinoma

RA Petrov, SR Mefedova, EY Yamansarov… - Molecular …, 2020 - ACS Publications
In this work, we have developed covalent and low molecular weight docetaxel delivery
systems based on conjugation with N-acetyl-d-galactosamine and studied their properties …

Targeting Wnt/EZH2/microRNA-708 signaling pathway inhibits neuroendocrine differentiation in prostate cancer

J Shan, MA Al-Muftah, MK Al-Kowari… - Cell death …, 2019 - nature.com
Prostate cancer (PC) castration resistance has been linked to the differentiation of PC
luminal cells into hormone-refractory neuroendocrine (NE) cells. However, the molecular …

[HTML][HTML] PSMA-targeted combination brusatol and docetaxel nanotherapeutics for the treatment of prostate cancer

TA Adekiya, T Hudson, O Bakare, EE Ameyaw… - Biomedicine & …, 2024 - Elsevier
Active targeting to cancer involves exploiting specific interactions between receptors on the
surface of cancer cells and targeting moieties conjugated to the surface of vectors such that …

Curcumin targets both apoptosis and necroptosis in acidity‐tolerant prostate carcinoma cells

YJ Lee, KS Park, SH Lee - BioMed research international, 2021 - Wiley Online Library
Objective. Curcumin, a major bioactive curcuminoid derived from the rhizome of Curcuma
longa, is known to have anticancer potential and is still under investigation. In this study, we …

Analysis of cabazitaxel‐resistant mechanism in human castration‐resistant prostate cancer

H Hongo, T Kosaka, M Oya - Cancer science, 2018 - Wiley Online Library
Cabazitaxel (CBZ) is approved for docetaxel‐resistant castration‐resistant prostate cancer
(CRPC). However, efficacy of CBZ for CRPC is limited and there are no effective treatments …

Targeting Nrf2-antioxidant signalling reverses acquired cabazitaxel resistance in prostate cancer cells

S Endo, M Kawai, M Hoshi, J Segawa… - The journal of …, 2021 - academic.oup.com
Prostate cancer is known to have a relatively good prognosis, but long-term hormone
therapy can lead to castration-resistant prostate cancer (CRPC). Cabazitaxel, a second …